Trial Profile
Melancholic Depression and Insomnia as Predictors of Response to Quetiapine in Patients With Major Depression
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Dec 2019
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 14 Nov 2019 Status changed from active, no longer recruiting to completed.
- 04 Jul 2017 New trial record